Novavax stock doubles after Sanofi deal marks 'new chapter' for company

The deal gave Novavax a much-needed cash boost as the company had flagged after a pandemic-era surge.

When asked if Sanofi had previously approached Novavax for partnership, CEO Jacobs said he couldn't comment. Novavax beat on earnings per share, at $1.08 versus consensus estimates of $1.05, but it missed on revenues, reporting $98.3 million compared to Wall Street expectations of more than $101 million.is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics.

If you’re looking to get into semiconductor stocks, SMH ETF is a great option. The post Like Nvidia Stock But Prefer ETFs? This Is the Best Semiconductor ETF to Invest in Artificial Intelligence appeared first on The Motley Fool Canada.Here's how these top Canadian energy infrastructure stocks could benefit from the AI data centre boom. The post With Natural Gas in Demand, 2 TSX Stocks Are Set to Heat Up appeared first on The Motley Fool Canada.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Novavax CEO on Sanofi deal: 'This is a new chapter in the history of our company'Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
مصدر: YahooFinanceCA - 🏆 47. / 63 اقرأ أكثر »